Find out more at www.kurk.au
Trent Scanlen is the Co-founder and CEO of KURK Biosciences, a vertically integrated biotech developing liquid micellar curcumin solutions. KURK operates a dedicated biotech lab and is partnering with Swansea Medical School to advance research on bioavailability and absorption.
Find out more at www.kurk.au